Ophthalmology – X-Linked Retinoschisis

What the Disorder Represents

X-linked retinoschisis (XLRS) is an inherited vitreoretinal dystrophy caused by pathogenic variants in the RS1 gene.

It predominantly affects males and is characterized by:

• Bilateral foveal schisis
• Reduced central vision
• Peripheral retinoschisis in many patients
• Characteristic electroretinographic abnormalities
• Risk of vitreous hemorrhage and retinal detachment

The hallmark structural finding is:

Spoke-wheel cystic/schitic separation of the macula, usually without fluorescein leakage.

The Genetic Basis

XLRS is caused by pathogenic variants in:

RS1 on chromosome Xp22.13.

RS1 encodes:

Retinoschisin

a secreted retinal protein important for:

• Cellular adhesion
• Retinal structural organization
• Synaptic integrity

Loss of functional retinoschisin weakens adhesion between retinal cells and promotes:

Splitting within retinal layers.

Important Modern Correction About Pathogenesis

Older descriptions proposed that XLRS was primarily a:

• Müller-cell disorder
• Retinal vascular developmental disorder

Modern evidence instead indicates that the fundamental defect is:

Abnormal retinoschisin-mediated retinal cellular adhesion and signaling.

Müller cells and retinal neurons may participate secondarily, but they are not considered the sole primary cause.

Inheritance Pattern

XLRS is:

X-linked recessive.

It therefore affects almost exclusively:

Males.

Carrier females are usually asymptomatic because they possess a second normal X chromosome, although rare retinal abnormalities can occur with skewed X-inactivation or unusual genetic circumstances.

Family Transmission Pattern

For an affected male:

• All daughters inherit the pathogenic RS1 variant and are typically carriers
• Sons do not inherit the father’s X chromosome

For a carrier female, each pregnancy has approximately:

• 50% chance that a son will be affected
• 50% chance that a daughter will be a carrier

Genetic counseling is therefore important.

When Patients Usually Present

XLRS frequently becomes apparent during:

Childhood, often in the first decade.

Presentation may include:

• Reduced visual acuity
• Strabismus
• Reading difficulty
• Abnormal school vision screening

Severe disease may present in infancy with:

• Nystagmus
• Strabismus
• Vitreous hemorrhage
• Retinal detachment

Typical Visual Acuity

Central visual acuity is often moderately reduced rather than profoundly poor.

Many patients remain in the approximate range of:

20/40–20/100

for years, although severity is highly variable.

Marked early visual loss should raise concern for:

• Macular detachment
• Vitreous hemorrhage
• Retinal detachment
• Advanced macular degeneration

The Classic Macular Appearance

The hallmark fundus appearance is:

Foveal schisis with radial folds or cystic spaces forming a spoke-wheel pattern.

On ophthalmoscopy, the fovea may show:

• Fine radiating striae
• Microcystic appearance
• Reduced foveal reflex

This may be subtle clinically and is much easier to recognize with:

OCT.

Why It Is Called Retinoschisis

“Schisis” means:

Splitting.

In XLRS, the neurosensory retina separates within its retinal layers rather than separating completely from the RPE as occurs in ordinary retinal detachment.

Optical Coherence Tomography

OCT is the most useful structural test.

It typically demonstrates:

• Intraretinal schisis cavities
• Foveal thickening
• Radial cyst-like spaces
• Bridging retinal tissue

The cavities may involve several layers, particularly:

• Inner nuclear layer
• Outer plexiform layer
• Outer nuclear layer
• Occasionally other retinal layers

Important Modern Correction About the Retinal Layer

Older teaching often emphasized splitting primarily in the:

Nerve fiber layer.

Modern OCT demonstrates that macular schisis can involve:

Multiple retinal layers, with the inner nuclear layer being particularly common.

Why This Is Not Ordinary Cystoid Macular Edema

The OCT can resemble severe cystoid macular edema.

However, XLRS schisis represents:

Structural splitting rather than primarily vascular leakage.

This distinction is reflected on fluorescein angiography.

Fluorescein Angiography

One of the most useful diagnostic clues is:

Little or no fluorescein leakage from the foveal cystic spaces.

This helps distinguish XLRS from true cystoid macular edema due to:

• Uveitis
• Diabetes
• Retinal vein occlusion
• Postoperative inflammation

Thus:

Cystic OCT spaces + little FA leakage in a young male = consider XLRS.

Peripheral Retinoschisis

Peripheral schisis develops in approximately:

Half of affected patients, although reported frequencies vary.

It most commonly involves the:

Inferotemporal retina.

It may appear as:

• Elevated transparent retina
• Bullous schisis
• Inner retinal holes
• Abnormal retinal vessels crossing the schisis cavity

Vascular Changes

Retinal vessels traversing the schisis may be:

• Poorly supported
• Sheathed
• Tortuous

Occasionally there may be:

• Peripheral ischemia
• Telangiectatic change
• Neovascularization

Fragile unsupported vessels contribute to the risk of:

Vitreous hemorrhage.

Vitreous Veils

A classic peripheral finding is:

Vitreous veils

consisting of thin residual inner retinal tissue associated with peripheral schisis.

These may accompany:

• Inner-layer breaks
• Abnormal vessels

and can be diagnostically helpful.

Electroretinography

Full-field ERG classically demonstrates an:

Electronegative response

in which the:

• a-wave is relatively preserved
• b-wave is disproportionately reduced

This reflects dysfunction of transmission between photoreceptors and inner retinal bipolar pathways.

Important Modern Correction About ERG

An electronegative ERG is:

Characteristic but not universal.

Not every patient has the classic pattern, particularly:

• Very young patients
• Mild phenotypes
• Advanced retinal degeneration

Therefore a normal or atypical ERG does:

Not completely exclude XLRS.

Why the a-Wave and b-Wave Differ

The a-wave primarily reflects:

Photoreceptor activity.

The b-wave depends more heavily on:

• Bipolar cells
• Müller-cell-associated inner retinal activity

XLRS disproportionately disrupts inner retinal signaling, producing:

A low b-wave relative to the a-wave.

Genetic Testing

Molecular testing for:

RS1 pathogenic variants

is now a central part of diagnosis.

It can:

• Confirm XLRS
• Distinguish it from phenocopies
• Identify carrier females
• Support family counseling
• Determine eligibility for clinical trials

When Genetic Testing Is Particularly Useful

Consider testing in a male with:

• Bilateral foveal schisis
• Electronegative ERG
• Family history of similar disease
• Peripheral schisis

It is also valuable in atypical cases where:

OCT findings alone are not definitive.

Fundus Autofluorescence

FAF may show:

• Altered macular autofluorescence
• Changes corresponding to chronic RPE stress or atrophy

It is supportive but less important diagnostically than:

• OCT
• ERG
• Genetic testing

Visual Fields

Visual field testing may demonstrate:

• Central or paracentral sensitivity loss
• Scotomas corresponding to peripheral schisis
• Field loss from retinal detachment

It is not usually necessary for diagnosis in young children.

How the Disease Changes With Age

During childhood and early adulthood:

• Foveal schisis may remain stable or fluctuate

With increasing age:

• Schisis cavities may partially collapse
• Macular thinning develops
• RPE changes increase
• Outer retinal atrophy may become more prominent

Thus an older patient with genetically confirmed XLRS may have:

Macular atrophy with relatively little visible schisis.

Why Vision Can Worsen Later in Life

Late visual decline is often due not to increasing schisis but to:

• Macular atrophy
• Photoreceptor degeneration
• RPE abnormalities
• Prior retinal detachment
• Recurrent vitreous hemorrhage

Strabismus and Amblyopia

Children may develop:

• Strabismus
• Anisometropia
• Amblyopia

These treatable causes of additional visual loss should not be overlooked simply because an inherited retinal disorder is present.

Refractive Error

Hyperopia has traditionally been described in XLRS, but refractive error is variable.

Patients should receive:

Full appropriate optical correction

to maximize visual development.

Important Diagnostic Alternatives

The differential includes:

• Enhanced S-cone syndrome / Goldmann-Favre phenotype
• Acquired degenerative retinoschisis
• Cystoid macular edema
• Familial exudative vitreoretinopathy
• Retinitis pigmentosa
• Retinal vasculitis
• Wagner syndrome
• Other inherited vitreoretinopathies

XLRS vs Acquired Degenerative Retinoschisis

XLRS

• Young male
• Bilateral
• Foveal schisis characteristic
• RS1 mutation
• Electronegative ERG may occur

Degenerative Retinoschisis

• Usually older adults
• Peripheral retinal splitting
• Typically no characteristic foveal schisis
• Not X-linked

XLRS vs Enhanced S-Cone Syndrome

Enhanced S-cone syndrome may also cause:

• Foveal schisis
• Peripheral retinal degeneration

However, patients commonly have:

• Prominent nyctalopia
• Characteristic pigmentary changes
• Distinctive ERG abnormalities involving enhanced S-cone function
• Autosomal recessive NR2E3 disease

XLRS vs True Cystoid Macular Edema

True CME generally shows:

Fluorescein leakage.

XLRS macular cavities typically show:

Minimal or absent leakage.

This is a classic examination distinction.

The Main Treatment Principle

There is currently:

No approved curative or disease-modifying treatment for XLRS.

Management focuses on:

• Maximizing useful vision
• Treating refractive error and amblyopia
• Reducing schisis in selected patients
• Detecting retinal complications early

Carbonic Anhydrase Inhibitors

Topical:

Dorzolamide

or systemic:

Acetazolamide

may reduce macular schisis cavities in some patients.

The response is variable.

What CAIs Can Achieve

Some patients demonstrate:

• Decreased central retinal thickness
• Smaller schisis cavities
• Modest improvement in visual acuity

Others show:

• Structural improvement without meaningful visual change
• No response
• Recurrence despite continued therapy

Therefore treatment should be assessed using:

Both OCT and visual function.

Why CAIs May Help

The exact mechanism is uncertain but may involve effects on:

• RPE ion transport
• Retinal fluid movement

The treatment does not correct the underlying:

RS1 genetic defect.

Topical vs Oral CAI

Topical dorzolamide is often tried first because systemic therapy has more adverse effects.

Oral acetazolamide may produce:

• Paresthesias
• Fatigue
• Electrolyte disturbances
• Nephrolithiasis
• Metabolic acidosis

Long-term treatment therefore requires appropriate monitoring.

Prophylactic Laser Is Not Recommended

Laser photocoagulation around uncomplicated peripheral schisis has historically been attempted.

Routine prophylactic laser is:

Not recommended.

It can:

• Create retinal breaks
• Increase traction
• Potentially precipitate rhegmatogenous retinal detachment

Observation is preferred unless there is a specific treatable complication.

Vitreous Hemorrhage

Vitreous hemorrhage may result from:

• Rupture of unsupported vessels
• Traction
• Less commonly retinal neovascularization

Many hemorrhages clear spontaneously.

When Vitrectomy Is Needed for Hemorrhage

Pars plana vitrectomy may be considered when hemorrhage is:

• Dense
• Recurrent
• Nonclearing
• Preventing evaluation of the retina

Earlier intervention may be considered in young children because prolonged visual deprivation can cause:

Amblyopia.

Retinal Detachment

Retinal detachment is one of the most important complications.

Mechanisms include:

• Outer retinal breaks
• Inner and outer layer breaks
• Vitreoretinal traction
• Combination of schisis and rhegmatogenous detachment

Why Retinal Detachment Is Technically Difficult

XLRS eyes may have:

• Fragile retina
• Abnormal vitreoretinal adhesion
• Large schisis cavities
• Thin inner retinal layers

These features complicate retinal repair.

Surgical Management of Retinal Detachment

Modern repair commonly uses:

Pars plana vitrectomy with internal tamponade

when significant traction or complex retinal breaks are present.

Additional options may include:

• Laser retinopexy around true breaks
• Gas or silicone oil tamponade
• Scleral buckle in selected configurations

Surgical planning should be individualized by a vitreoretinal surgeon.

Why Not Every Schisis Cavity Needs Surgery

A stable peripheral schisis cavity without:

• Progressive retinal detachment
• Vision-threatening extension
• Significant traction

usually requires:

Observation rather than intervention.

Operating on structurally fragile retina can create more harm than benefit.

Retinal Neovascularization

True neovascularization is uncommon but may occur with peripheral ischemia.

Management may include:

• Laser photocoagulation to ischemic retina
• Anti-VEGF as an adjunct in selected cases

Treatment is directed at the complication rather than the underlying XLRS.

Role of Gene Therapy

Because XLRS results from loss of a secreted retinal protein, it has been an attractive target for:

RS1 gene-replacement therapy.

Human clinical trials using intravitreal gene therapy have demonstrated:

• Biological activity
• Significant inflammatory challenges
• Variable structural and functional benefit

As of current clinical practice:

No RS1 gene therapy is approved for routine treatment.

Why Gene Therapy Remains Challenging

Effective treatment must deliver functional RS1 broadly across the retina while avoiding:

• Intraocular inflammation
• Immune responses to viral vectors
• Retinal toxicity

Research continues.

Low-Vision Support

Patients with significant central visual impairment may benefit from:

• Magnification
• Electronic reading aids
• Classroom accommodations
• High-contrast materials
• Low-vision rehabilitation

Children should receive appropriate educational support early.

Activity and Eye Protection

There is no universal evidence-based prohibition against ordinary physical activity.

However, because vitreous hemorrhage and retinal detachment can occur:

• Significant ocular trauma should be avoided
• Protective eyewear is reasonable during high-risk activities

Restrictions should be individualized rather than imposing blanket sports bans.

Follow-Up Strategy

Patients require regular lifelong retinal follow-up.

Monitor:

• Visual acuity
• Refraction
• Strabismus/amblyopia
• Macular OCT
• Peripheral retina
• Vitreous hemorrhage
• Retinal detachment

The interval depends on:

• Age
• Severity
• Peripheral schisis
• Previous complications

Symptoms Requiring Urgent Reassessment

Patients and families should seek prompt retinal evaluation for:

• Sudden increase in floaters
• Photopsias
• Curtain or field defect
• Sudden reduction in vision

These can indicate:

• Vitreous hemorrhage
• Retinal tear
• Retinal detachment

Expected Long-Term Course

XLRS usually progresses:

Slowly.

Many patients retain useful central vision through childhood and early adulthood.

Later deterioration can occur from:

• Macular atrophy
• Retinal detachment
• Recurrent hemorrhage
• Outer retinal degeneration

The course varies considerably even among members of the same family.

Major Causes of Permanent Visual Loss

These include:

• Macular atrophy
• Retinal detachment
• Recurrent vitreous hemorrhage
• Amblyopia
• Advanced outer retinal degeneration

The schisis cavities themselves do not always correlate directly with visual acuity.

High-Yield Takeaways

• X-linked retinoschisis is an X-linked recessive inherited retinal dystrophy caused by pathogenic variants in RS1, which encodes retinoschisin.
• It affects almost exclusively males, usually presenting during childhood with reduced central vision.
• The hallmark is bilateral foveal schisis with a spoke-wheel appearance.
• Peripheral schisis occurs in roughly half of patients, classically inferotemporally.
• Modern OCT shows schisis involving multiple retinal layers, particularly the inner nuclear layer; it is not confined to the nerve fiber layer.
• The macular cavities resemble CME on OCT but typically show little or no fluorescein leakage.
• A classic ERG demonstrates an electronegative response with disproportionately reduced b-wave, but this is not present in every patient.
• RS1 genetic testing is now a central diagnostic tool and enables carrier testing and genetic counseling.
• Older patients may show macular atrophy with collapse of previously obvious schisis cavities.
• Treat refractive error, strabismus, and amblyopia aggressively because these can add preventable visual loss.
• Topical dorzolamide or oral acetazolamide may reduce macular schisis in selected patients, although visual benefit is variable.
• Routine prophylactic laser around peripheral schisis is not recommended because it may increase retinal complications.
• Vitreous hemorrhage often clears spontaneously, but persistent or dense hemorrhage may require vitrectomy, especially during the amblyogenic years.
• Retinal detachment may result from retinal breaks and vitreoretinal traction and frequently requires pars plana vitrectomy with individualized tamponade.
• True retinal neovascularization is uncommon; when present, treatment targets the ischemic complication rather than the inherited schisis itself.
• No approved curative or RS1 gene-replacement therapy currently exists, although gene therapy remains under investigation.
• Sudden floaters, photopsias, field loss, or abrupt visual decline require urgent examination for vitreous hemorrhage or retinal detachment.
• The disease is usually slowly progressive, with late visual decline often resulting from macular atrophy rather than simply enlargement of the schisis cavities.
• Lifelong retinal surveillance and genetic counseling are essential.

High-Yield Takeaways